SEC Form 4 · accession 0001209191-18-022442
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Daruwala
Officer — Chief Operating Officer
Period of report
Mar 29, 2018
Accepted (ET)
Apr 2, 2018 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $4.00 | Mar 29, 2018 | A | 72,000 | A | — | Mar 28, 2028 | Common Stock | 72,000 | 72,000 | D |
Explanation of responses
- F1The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 29, 2018.